Sandler Capital Management’s AstraZeneca AZN Stock Holding History

Sandler Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,500	Closed	-$210K	–	147
2025 Q2	$210K	Sell	1,500 -500	-25%	-$70.1K	0.07%	142
2025 Q1	$294K	Hold	2,000	–	–	0.1%	111
2024 Q4	$262K	Hold	2,000	–	–	0.04%	148
2024 Q3	$312K	Hold	2,000	–	–	0.06%	136
2024 Q2	$312K	Hold	2,000	–	–	0.06%	116
2024 Q1	$271K	Hold	2,000	–	–	0.03%	132
2023 Q4	$269K	Hold	2,000	–	–	0.03%	101
2023 Q3	$271K	Hold	2,000	–	–	0.05%	102
2023 Q2	$286K	Hold	2,000	–	–	0.04%	85
2023 Q1	$278K	Hold	2,000	–	–	0.05%	87
2022 Q4	$271K	Hold	2,000	–	–	0.04%	81
2022 Q3	$219K	Buy	+2,000	New	+$254K	0.05%	77
2014 Q3	–	Sell	-266,000	Closed	-$19.8M	–	187
2014 Q2	$19.8M	Buy	+266,000	New	+$19.2M	1.23%	34

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return